Zhejiang Huakang Pharmaceutical Co., Ltd. (605077)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
11. 14
-0.1
-0.8897%
¥
4.59B Market Cap
- P/E Ratio
2.8% Div Yield
3.59M Volume
- Eps
¥ 11.24
Previous Close Want to track 605077 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
605077 closed today lower at ¥11.14, a decrease of -0.8897% from yesterday's close, completing a monthly increase of 3.1481% or ¥0.34. Over the past 12 months, 605077 stock lost -24.9326%.
605077 pays dividends to its shareholders, with the most recent payment made on Jun 17, 2026. The next estimated payment will be in In 4 months on Dec 17, 2026 for a total of ¥0.3.
The last earnings report, released on Apr 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zhejiang Huakang Pharmaceutical Co., Ltd. has completed 3 stock splits, with the recent split occurring on May 28, 2024.
The company's stock is traded on one exchange.
605077 Chart
People also search for
Zhejiang Huakang Pharmaceutical Co., Ltd. (605077) FAQ
What is the stock price today?
The current price is ¥11.14.
On which exchange is it traded?
Zhejiang Huakang Pharmaceutical Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 605077.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.8%.
What is its market cap?
As of today, the market cap is 4.59B.
Has Zhejiang Huakang Pharmaceutical Co., Ltd. ever had a stock split?
Zhejiang Huakang Pharmaceutical Co., Ltd. had 3 splits and the recent split was on May 28, 2024.
Zhejiang Huakang Pharmaceutical Co., Ltd. Profile
| Chemicals Industry | Materials Sector | Mr. Deshui Chen CEO | SSE Exchange | CNE100005477 ISIN |
| CN Country | - Employees | 17 Jun 2026 Last Dividend | 19 May 2021 Last Split | - IPO Date |
Overview
Zhejiang Huakang Pharmaceutical Co., Ltd. is a distinguished enterprise focused on the research, production, and international sale of polyols and starch sugar. Since its establishment in 2001, the company has developed a strong presence within the food and pharmaceutical industries, providing high-quality sugar substitutes and additives. Based in Quzhou, China, Zhejiang Huakang Pharmaceutical has committed itself to innovation and excellence, catering to a global clientele with its superior products.
Products and Services
- Xylitol: A polyol that mimics the sweetness of sugar closely. It is widely used as a sugar substitute in various food products, including sugar-free gum and candy, due to its dental benefits and lower caloric content compared to traditional sugar.
- Sorbitol: This is a sugar alcohol in the form of a white crystal powder or colorless liquid. Sorbitol is often utilized in diet foods, sugar-free candies, and other oral care products as it provides sweetness with fewer calories.
- Maltitol: Another sugar alcohol, maltitol is used as a sugar substitute because it provides a similar sweetness while having less impact on blood glucose levels. It's commonly found in sugar-free chocolates and other low-calorie snacks.
- Xylose: Used primarily in the production of xylitol, xylose is a key component in creating alternative sweeteners. It plays a critical role in the company's sweetener production line.
- L-Arabinose: This can be used as a replacement for sucrose or as an additive in various food and drink applications. L-arabinose is valued for its ability to inhibit the absorption of sucrose, helping in the management of blood sugar levels and weight.
Contact Information
Address: 18 Huagong Road, Quzhou, China, 324302
Phone: 86 57 0603 5888
Website: https://www.huakangpharma.com
